Literature DB >> 24316422

Objective area measurement technique for choroidal neovascularization from fluorescein angiography.

Micah J Guthrie1, Christian R Osswald1, Nicole L Valio2, William F Mieler3, Jennifer J Kang-Mieler4.   

Abstract

The purpose of this study was to develop a non-biased method of quantitatively measuring choroidal neovascularization (CNV) areas based on late-phase fluorescein angiography (FA) images. Experimental CNV was induced in Long Evans rats by laser disruption of the Bruch's membrane. FA was performed weekly for 5weeks. Multi-Otsu thresholding (MOT) was used to quantify CNV in late-phase FA images from both experimental rodent CNV and wet age-related macular degeneration (wAMD) patients. Images were automatically thresholded into three levels based on the image histogram, with the highest level containing CNV. To determine the technique's ability to quantify CNV areas, rats were given either triamcinolone acetonide or dexamethasone sodium phosphate to treat CNV and compared to untreated rats. The rat CNV lesion areas measured from 5-week histology sections from each treatment group were compared to areas measured from the corresponding FA images. MOT was able to detect statistical decreases in rodent CNV area in the treatment groups versus control from weeks 3 through 5. The ratio of CNV area measured from histology to area measured from FA images was not statistically different between groups. Finally, to determine the usefulness of MOT on pathological morphologies of CNV, MOT was performed on late-phase FA images from patients with classic and diffuse CNV. The technique was able to segment classical CNV in wAMD patients, but performed poorly with diffuse CNV. MOT provides a robust, objective, and quantifiable area measurement of CNV lesion area in both experimentally-induced and pathological CNV. The results indicate that MOT could be a useful research tool in helping evaluate the effects of therapeutics on CNV growth.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24316422      PMCID: PMC3946980          DOI: 10.1016/j.mvr.2013.11.005

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  28 in total

Review 1.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

2.  A new model of experimental choroidal neovascularization in the rat.

Authors:  E T Dobi; C A Puliafito; M Destro
Journal:  Arch Ophthalmol       Date:  1989-02

3.  Pathogenesis of laser-induced choroidal subretinal neovascularization.

Authors:  H Miller; B Miller; T Ishibashi; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-05       Impact factor: 4.799

4.  Quantitative image analysis of laser-induced choroidal neovascularization in rat.

Authors:  J L Edelman; M R Castro
Journal:  Exp Eye Res       Date:  2000-11       Impact factor: 3.467

5.  COX-2-selective inhibitor, etodolac, suppresses choroidal neovascularization in a mice model.

Authors:  Hidenori Takahashi; Yasuo Yanagi; Yasuhiro Tamaki; Saiko Uchida; Kimimasa Muranaka
Journal:  Biochem Biophys Res Commun       Date:  2004-12-10       Impact factor: 3.575

6.  Improved assessment of laser-induced choroidal neovascularization.

Authors:  Hassanain S Toma; Joshua M Barnett; John S Penn; Stephen J Kim
Journal:  Microvasc Res       Date:  2010-06-08       Impact factor: 3.514

7.  The effects of cross-linked thermo-responsive PNIPAAm-based hydrogel injection on retinal function.

Authors:  Sanja B Turturro; Micah J Guthrie; Alyssa A Appel; Pawel W Drapala; Eric M Brey; Victor H Pérez-Luna; William F Mieler; Jennifer J Kang-Mieler
Journal:  Biomaterials       Date:  2011-02-12       Impact factor: 12.479

8.  Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.

Authors:  Albert J Augustin; Stephan Puls; Indre Offermann
Journal:  Retina       Date:  2007-02       Impact factor: 4.256

9.  Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Authors:  J K Challa; M C Gillies; P L Penfold; J F Gyory; A B Hunyor; F A Billson
Journal:  Aust N Z J Ophthalmol       Date:  1998-11

10.  Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina.

Authors:  Yue Ming; Peep V Algvere; Anne Odergren; Lennart Berglin; Ingeborg van der Ploeg; Stefan Seregard; Anders Kvanta
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

View more
  6 in total

1.  Quantitative spatial and temporal analysis of fluorescein angiography dynamics in the eye.

Authors:  Flora Hui; Christine T O Nguyen; Phillip A Bedggood; Zheng He; Rebecca L Fish; Rachel Gurrell; Algis J Vingrys; Bang V Bui
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.

Authors:  Min Zhao; Wankun Xie; Shu-Huai Tsai; Travis W Hein; Brent A Rocke; Lih Kuo; Robert H Rosa
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

3.  Neuropilin 1 Involvement in Choroidal and Retinal Neovascularisation.

Authors:  Patricia Fernández-Robredo; Senthil Selvam; Michael B Powner; Dawn A Sim; Marcus Fruttiger
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

4.  Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.

Authors:  Liheng Shi; Min Zhao; Colette A Abbey; Shu-Huai Tsai; Wankun Xie; Dylan Pham; Samantha Chapman; Kayla J Bayless; Travis W Hein; Robert H Rosa; Michael L Ko; Lih Kuo; Gladys Y-P Ko
Journal:  J Am Heart Assoc       Date:  2019-11-08       Impact factor: 5.501

5.  Quantification of retinal blood leakage in fundus fluorescein angiography in a retinal angiogenesis model.

Authors:  Cesar H Comin; Demetrios I Tsirukis; Ye Sun; Xiaoyin Xu
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

6.  Treatment Efficacy and Biocompatibility of a Biodegradable Aflibercept-Loaded Microsphere-Hydrogel Drug Delivery System.

Authors:  Wenqiang Liu; Anessa Puskar Tawakol; Kayla M Rudeen; William F Mieler; Jennifer J Kang-Mieler
Journal:  Transl Vis Sci Technol       Date:  2020-10-13       Impact factor: 3.283

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.